Oncology & Cancer

Clinical trial results for BIND-014 presented at AACR 2013

The nanoparticle drug BIND-014 is effective against multiple solid tumors, according to results generated by the Translational Genomics Research Institute (TGen) and Scottsdale Healthcare, and presented today at the American ...

Oncology & Cancer

First study of clonal evolution in Maxillary Sinus Carcinoma

Knowing how tumors evolve can lead to new treatments that could help prevent cancer from recurring, according to a study published today by the Translational Genomics Research Institute (TGen) and Scottsdale Healthcare.

page 4 from 7